Background/aims Ocular surface infections remain a major cause of visual loss worldwide, yet diagnosis often relies on slow ...

A California-based company is planning a new type of ranch in the heart of West Texas, measured not in herds of cattle, but in gigawatts of electricity. At the site in Fort Stockton, Pacifico Energy ...

More than 10 percent of U.S. adults take GLP-1 drugs. But not all of them are taking full doses. Around one in seven users has “microdosed” injections, a recent survey by the health tracking app ...

Nvidia announced chips that will be used for space missions at the GTC 2026 AI conference. Orbital data centers have been an increasingly popular proposition as AI demand tests Earth's energy ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...

"This is a challenge unlike any we have encountered thus far in this new era of commercial space." When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works ...

“RESIST SAYING, ‘this will be no panacea’. When you find something that is a panacea, that will indeed be news.” This wise advice once appeared in The Economist’s Style Guide, and the first part is ...

Google announced Tuesday that it will build a data center in Minnesota that’s backed by 1.9 gigawatts of clean power, including a massive 300-megawatt battery made by startup Form Energy. The new data ...

This summer, Johns Hopkins will host a graduate student fellowship designed to prepare emerging data scientists to leverage the latest developments in generative artificial intelligence and machine ...

A team at Microsoft Research combined lasers, machine learning and tiny glass rectangles to demonstrate a new robotic data storage system that could, in theory, still be readable 10,000 years from now ...

Illinois Gov. JB Pritzker is expected Wednesday to call for a two-year suspension of tax incentives offered to develop data centers amid growing scrutiny over their rapid expansion and impact on ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...